Real-World Assessment of Baseline Demographic and Clinical Characteristics Among Patients Using INP104 in the United States

Presented at the AHS 65th Annual Scientific Meeting, June 15-18, 2023, Austin, Texas Authors: Gokani T, Nguyen L, Vann R, Gutierrez J, Ray S, Aurora S One sentence summary: A longitudinal, retrospective database study in the United States that assessed the baseline characteristics and comorbidities of migraine patients who were treated with INP104 reports that most […] The post Real-World Assessment of Baseline Demographic and Clinical Characteristics Among Patients Using INP104 in the United States appeared first on Impel Pharmaceuticals .